Marie-jose Lecomte
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Erratum: Efficacy and safety of SENS-501, a dual-AAV otoferlin gene therapy, for DFNB9 congenital deafness.
Journal: Molecular therapy. Advances
Published: August 07, 2026
Efficacy and safety of SENS-501, a dual-AAV otoferlin gene therapy, for DFNB9 congenital deafness.
Journal: Molecular therapy. Advances
Published: December 04, 2025
Dual AAV gene therapy achieves recovery of hearing and auditory processing in a DFNB16 mouse model.
Journal: Clinical and translational medicine
Published: July 11, 2025
Adeno-associated virus-based rescue of Myo7a expression restores hair-cell function and improves hearing thresholds in a USH1B mouse strain.
Journal: The Journal of physiology
Published: June 18, 2025
Cochlear gene therapy restores hearing and auditory processing in an atypical DFNB9 mouse model.
Journal: Communications medicine
Published: September 24, 2024
Towards the Clinical Application of Gene Therapy for Genetic Inner Ear Diseases.
Journal: Journal of clinical medicine
Published: December 22, 2022
Airborne concentrations and chemical considerations of radioactive ruthenium from an undeclared major nuclear release in 2017.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 28, 2019
Aggregation of Engineered Human β-Cells Into Pseudoislets: Insulin Secretion and Gene Expression Profile in Normoxic and Hypoxic Milieu.
Journal: Cell medicine
Published: December 23, 2016
Last Updated: 09/26/2026